» Articles » PMID: 30187503

Unexpected Finding of Uniparental Disomy Mosaicism in Term Placentas: Is It a Common Feature in Trisomic Placentas?

Abstract

Objective: Non-invasive prenatal testing (NIPT) detects placental chromosome aberrations. When amniocentesis reveals a normal karyotype, confined placental mosaicism (CPM) may be assumed. In order to confirm this, placental cytogenetic studies were performed.

Method: NIPT was conducted in the course of the Dutch TRIDENT study. Placentas of 10 cases with NIPT results indicating an autosomal trisomy and showing a normal (N = 9) or low mosaic karyotype (N = 1) in amniotic fluid (AF) were investigated. The cytotrophoblast as well as the mesenchymal core of two to four placental chorionic villi biopsies were studied with single nucleotide polymorphism (SNP) array. Clinical outcome data were collected.

Results: In 10/10 cases, CPM was proven. In 3/10 cases trisomy/uniparental disomy (UPD)/biparental disomy (BPD) mosaicism was discovered. In 2/3 cases, all three cell lines were present in the placenta, whereas BPD was found in AF. In 1/3 cases trisomy 22/UPD22 was present in AF while trisomy 22/BPD22 mosaicism was found in the placenta. Five of 10 pregnancies were affected with pre-eclampsia, low birth weight, preterm delivery, and/or congenital malformations.

Conclusion: The presence of trisomy/UPD/BPD mosaicism in 3/10 cases that we investigated proves that trisomic zygote rescue may involve multiple rescue events during early embryogenesis. UPD mosaicism, when present in crucial fetal tissues, may explain the abnormal phenotype in undiagnosed cases.

Citing Articles

Detecting mitochondrial mutations associated with aminoglycoside ototoxicity by noninvasive prenatal testing.

Huang Q, Liu Y, Lei W, Liang J, Wang Y, Zheng M J Clin Lab Anal. 2022; 37(1):e24827.

PMID: 36579624 PMC: 9833975. DOI: 10.1002/jcla.24827.


Preimplantation chromosomal mosaics, chimaeras and confined placental mosaicism.

West J, Everett C Reprod Fertil. 2022; 3(2):R66-R90.

PMID: 35514539 PMC: 9066951. DOI: 10.1530/RAF-21-0095.


Clinical Selection of Prenatal Diagnostic Techniques Following Positive Noninvasive Prenatal Screening Results in Southwest China.

Jing X, Liu H, Zhu Q, Liu S, Liu J, Bai T Front Genet. 2022; 12:811414.

PMID: 35154255 PMC: 8834880. DOI: 10.3389/fgene.2021.811414.


Prenatal Detection of Uniparental Disomies (UPD): Intended and Incidental Finding in the Era of Next Generation Genomics.

Eggermann T Genes (Basel). 2020; 11(12).

PMID: 33287348 PMC: 7761756. DOI: 10.3390/genes11121454.


Placental studies elucidate discrepancies between NIPT showing a structural chromosome aberration and a differently abnormal fetal karyotype.

Van Opstal D, van Veen S, Joosten M, Diderich K, Govaerts L, Polak J Prenat Diagn. 2019; 39(11):1016-1025.

PMID: 31321790 PMC: 6899775. DOI: 10.1002/pd.5531.


References
1.
Fiorentino F, Bono S, Pizzuti F, Duca S, Polverari A, Faieta M . The clinical utility of genome-wide non invasive prenatal screening. Prenat Diagn. 2017; 37(6):593-601. DOI: 10.1002/pd.5053. View

2.
Izumi K, Santani A, Deardorff M, Feret H, Tischler T, Thiel B . Mosaic maternal uniparental disomy of chromosome 15 in Prader-Willi syndrome: utility of genome-wide SNP array. Am J Med Genet A. 2012; 161A(1):166-71. DOI: 10.1002/ajmg.a.35625. View

3.
Henderson K, Shaw T, Barrett I, Telenius A, Wilson R, Kalousek D . Distribution of mosaicism in human placentae. Hum Genet. 1996; 97(5):650-4. DOI: 10.1007/BF02281877. View

4.
Pescia G, Guex N, Iseli C, Brennan L, Osteras M, Xenarios I . Cell-free DNA testing of an extended range of chromosomal anomalies: clinical experience with 6,388 consecutive cases. Genet Med. 2016; 19(2):169-175. PMC: 5303761. DOI: 10.1038/gim.2016.72. View

5.
Wang J, Vaccarello-Cruz M, Ross L, Owen R, Pratt V, Lightman K . Mosaic isochromosome 15q and maternal uniparental isodisomy for chromosome 15 in a patient with morbid obesity and variant PWS-like phenotype. Am J Med Genet A. 2013; 161A(7):1695-701. DOI: 10.1002/ajmg.a.35939. View